Risk-characterization framework for decision-making at the food and drug administration

Risk-characterization framework for decision-making at the food and drug administration / Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.

Saved in:
Bibliographic Details
:
National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.
TeilnehmendeR:
National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.
ProQuest (Firm)
Year of Publication:2011
Language:English
Online Access:
Physical Description:xiv, 192 p.
Tags: Add Tag
No Tags, Be the first to tag this record!
id 5003378782
ctrlnum (MiAaPQ)5003378782
(Au-PeEL)EBL3378782
(CaPaEBR)ebr10478232
(CaONFJC)MIL313516
(OCoLC)923283476
collection bib_alma
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01432nam a2200325Ia 4500</leader><controlfield tag="001">5003378782</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">110314s2011 dcu sb 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309212809</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5003378782</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL3378782</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10478232</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaONFJC)MIL313516</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)923283476</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RA445</subfield><subfield code="b">.R57 2011</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Risk-characterization framework for decision-making at the food and drug administration</subfield><subfield code="h">[electronic resource] /</subfield><subfield code="c">Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington, DC :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">2011.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiv, 192 p.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="610" ind1="1" ind2="0"><subfield code="a">United States.</subfield><subfield code="b">Food and Drug Administration</subfield><subfield code="x">Management.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Public health</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Research Council (U.S.).</subfield><subfield code="b">Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3378782</subfield><subfield code="z">Click to View</subfield></datafield></record></collection>
record_format marc
spelling Risk-characterization framework for decision-making at the food and drug administration [electronic resource] / Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.
Washington, DC : National Academies Press, 2011.
xiv, 192 p.
Includes bibliographical references.
Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
United States. Food and Drug Administration Management.
Public health United States.
Electronic books.
National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.
ProQuest (Firm)
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3378782 Click to View
language English
format Electronic
eBook
author2 National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.
ProQuest (Firm)
author_facet National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.
ProQuest (Firm)
National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.
ProQuest (Firm)
author2_role TeilnehmendeR
TeilnehmendeR
author_corporate National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.
ProQuest (Firm)
title Risk-characterization framework for decision-making at the food and drug administration
spellingShingle Risk-characterization framework for decision-making at the food and drug administration
title_full Risk-characterization framework for decision-making at the food and drug administration [electronic resource] / Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.
title_fullStr Risk-characterization framework for decision-making at the food and drug administration [electronic resource] / Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.
title_full_unstemmed Risk-characterization framework for decision-making at the food and drug administration [electronic resource] / Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.
title_auth Risk-characterization framework for decision-making at the food and drug administration
title_new Risk-characterization framework for decision-making at the food and drug administration
title_sort risk-characterization framework for decision-making at the food and drug administration
publisher National Academies Press,
publishDate 2011
physical xiv, 192 p.
callnumber-first R - Medicine
callnumber-subject RA - Public Medicine
callnumber-label RA445
callnumber-sort RA 3445 R57 42011
genre Electronic books.
genre_facet Electronic books.
geographic_facet United States.
url https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3378782
illustrated Not Illustrated
oclc_num 923283476
work_keys_str_mv AT nationalresearchcounciluscommitteeonrankingfdaproductcategoriesbasedonhealthconsequencesphaseii riskcharacterizationframeworkfordecisionmakingatthefoodanddrugadministration
AT proquestfirm riskcharacterizationframeworkfordecisionmakingatthefoodanddrugadministration
status_str n
ids_txt_mv (MiAaPQ)5003378782
(Au-PeEL)EBL3378782
(CaPaEBR)ebr10478232
(CaONFJC)MIL313516
(OCoLC)923283476
is_hierarchy_title Risk-characterization framework for decision-making at the food and drug administration
author2_original_writing_str_mv noLinkedField
noLinkedField
_version_ 1792330865736417280

Similar Items